A detailed history of Tredje Ap Fonden transactions in Merck & Co., Inc. stock. As of the latest transaction made, Tredje Ap Fonden holds 726,292 shares of MRK stock, worth $69.9 Million. This represents 0.77% of its overall portfolio holdings.

Number of Shares
726,292
Previous 908,422 20.05%
Holding current value
$69.9 Million
Previous $112 Million 26.66%
% of portfolio
0.77%
Previous 1.1%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$111.15 - $128.97 $20.2 Million - $23.5 Million
-182,130 Reduced 20.05%
726,292 $82.5 Million
Q2 2024

Aug 12, 2024

BUY
$123.8 - $132.96 $6.12 Million - $6.57 Million
49,400 Added 5.75%
908,422 $112 Million
Q1 2024

May 13, 2024

BUY
$113.24 - $131.95 $29.1 Million - $33.9 Million
257,000 Added 42.69%
859,022 $113 Million
Q4 2023

Feb 12, 2024

BUY
$100.18 - $109.02 $6.73 Million - $7.32 Million
67,130 Added 12.55%
602,022 $65.6 Million
Q3 2023

Nov 09, 2023

BUY
$102.95 - $114.33 $1.08 Million - $1.19 Million
10,452 Added 1.99%
534,892 $55.1 Million
Q2 2023

Aug 11, 2023

BUY
$108.61 - $118.38 $2.73 Million - $2.98 Million
25,153 Added 5.04%
524,440 $60.5 Million
Q1 2023

May 10, 2023

SELL
$102.94 - $114.86 $4.48 Million - $5 Million
-43,553 Reduced 8.02%
499,287 $53.1 Million
Q4 2022

Feb 10, 2023

BUY
$87.44 - $112.11 $8.47 Million - $10.9 Million
96,824 Added 21.71%
542,840 $60.2 Million
Q3 2022

Nov 10, 2022

BUY
$84.53 - $94.96 $15.5 Million - $17.5 Million
183,813 Added 70.1%
446,016 $38.4 Million
Q2 2020

Aug 11, 2020

SELL
$70.42 - $80.13 $1.77 Million - $2.01 Million
-25,102 Reduced 8.74%
262,203 $20.3 Million
Q1 2020

May 11, 2020

SELL
$63.36 - $87.82 $719,896 - $997,810
-11,362 Reduced 3.8%
287,305 $22.4 Million
Q4 2019

Feb 10, 2020

SELL
$77.58 - $87.54 $1.83 Million - $2.07 Million
-23,622 Reduced 7.33%
298,667 $27.3 Million
Q3 2019

Nov 12, 2019

BUY
$76.08 - $82.93 $206,328 - $224,906
2,712 Added 0.85%
322,289 $27.3 Million
Q2 2019

Aug 09, 2019

SELL
$69.84 - $81.59 $419,459 - $490,029
-6,006 Reduced 1.84%
319,577 $27 Million
Q1 2019

May 10, 2019

BUY
$69.58 - $79.36 $1.3 Million - $1.48 Million
18,654 Added 6.08%
325,583 $27.3 Million
Q4 2018

Feb 11, 2019

SELL
$65.24 - $75.71 $4.69 Million - $5.45 Million
-71,943 Reduced 18.99%
306,929 $23.6 Million
Q3 2018

Nov 13, 2018

SELL
$57.69 - $67.84 $5.99 Million - $7.04 Million
-103,828 Reduced 21.51%
378,872 $27.1 Million
Q2 2018

Aug 09, 2018

BUY
$50.83 - $59.72 $371,872 - $436,911
7,316 Added 1.54%
482,700 $29.5 Million
Q1 2018

May 09, 2018

BUY
$50.96 - $59.23 $927,828 - $1.08 Million
18,207 Added 3.98%
475,384 $26.1 Million
Q4 2017

Feb 12, 2018

BUY
$51.62 - $61.64 $3.16 Million - $3.77 Million
61,220 Added 15.46%
457,177 $25.9 Million
Q3 2017

Nov 13, 2017

BUY
$58.67 - $63.13 $23.2 Million - $25 Million
395,957
395,957 $25.5 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $244B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Tredje Ap Fonden Portfolio

Follow Tredje Ap Fonden and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tredje Ap Fonden, based on Form 13F filings with the SEC.

News

Stay updated on Tredje Ap Fonden with notifications on news.